Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Buy
4,155
+26
+0.6% +$9.27K 0.52% 41
2025
Q4
$1.35M Buy
4,129
+28
+0.7% +$8.88K 0.5% 40
2025
Q3
$1.16M Buy
4,101
+32
+0.8% +$9.28K 0.46% 46
2025
Q2
$1.17M Buy
4,069
+331
+9% +$93.8K 0.48% 45
2025
Q1
$1.17M Buy
3,738
+27
+0.7% +$7.97K 0.57% 38
2024
Q4
$967K Buy
3,711
+30
+0.8% +$8.9K 0.48% 42
2024
Q3
$1.19M Buy
3,681
+25
+0.7% +$8.18K 0.61% 35
2024
Q2
$1.14M Buy
3,656
+39
+1% +$11.5K 0.65% 35
2024
Q1
$1.03M Buy
3,617
+30
+0.8% +$8.78K 0.6% 35
2023
Q4
$1.03M Buy
3,587
+28
+0.8% +$7.63K 0.68% 33
2023
Q3
$957K Buy
3,559
+28
+0.8% +$6.99K 0.7% 33
2023
Q2
$784K Buy
3,531
+34
+1% +$7.89K 0.57% 37
2023
Q1
$845K Buy
3,497
+32
+0.9% +$7.86K 0.63% 36
2022
Q4
$910K Buy
3,465
+24
+0.7% +$6.43K 0.75% 35
2022
Q3
$776K Buy
3,441
+27
+0.8% +$6.54K 0.72% 36
2022
Q2
$831K Buy
3,414
+26
+0.8% +$6.37K 0.79% 35
2022
Q1
$819K Buy
3,388
+28
+0.8% +$6.43K 0.69% 35
2021
Q4
$756K Buy
+3,360
New +$709K 0.63% 37

Other funds holding AMGN

TAGStone Capital's AMGN Position: Q1 2026 in Review

TAGStone Capital increased its Amgen (AMGN) stake by 0.63% in Q1 2026, buying an estimated $9.27K and bringing the position to 4,155 shares worth $1.46M. The position accounts for 0.52% of the portfolio, ranked #41.

TAGStone Capital first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • TAGStone Capital held 4,155 shares of Amgen worth $1.46M as of Q1 2026.
  • TAGStone Capital bought 26 Amgen shares in Q1 2026, an estimated $9.27K.
  • Amgen made up 0.52% of TAGStone Capital's portfolio in Q1 2026, its #41 holding.
  • TAGStone Capital first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TAGStone Capital's 13F filing for Q1 2026, filed 11 May 2026.